Paederia scandens (Lour.) Merrill (Rubiaceae) is a climbing plant, distributed in southern region of the Korea Peninsula, Vietnam, India, China, Japan, the Philippines, and the USA. 1 The roots, leaves, bark, and fruits of this plant have been used to treat jaundice, dysentery, and dyspepsia, in Korea. 2 Previous investigations on this plant have reported the occurrence of iridoid glycosides 1, 2, 3 and the pharmacological activities including the inhibitory effects against Epstein-Barr virus activation 4 and xanthine oxidase, 5 antinociceptive activity, 6,7 and uricosuric effect. 5 The present study described the isolation of two new phenylpropanoid glycosides 1 and 2, along with two known flavonoid glycosides 3 and 4 from the aerial parts of P. scandens. The structures of the known compounds 3 and 4 were confirmed by interpreting the measured 1D and 2D NMR spectroscopic data and comparing these data with the published values, rutin, and kaempferol-3-O-rutinoside, respectively. 8 It is the first time that these isolates have been isolated from this plant.
Compound 1 was obtained as an amorphous powder, and its molecular formula of C22H32O13 was confirmed by the presence of a sodiated molecular ion [M+Na] + at m/z 527.1745 in the HR FAB-MS. The 1 H-NMR spectrum ( H COSY and TOCSY. These data enabled the assignment of the signals belonging to a glucopyranoside together with DEPT and HMQC data. The remaining part was assigned as acyclic sugar moiety, a hexane-1,2,3,4,5-pentanol, by using the sequentially observed correlations from H-1″ to H-6″ in the 1 H-1 H COSY and the partially observed correlations of H-1″ to H-2″, H-3″, and H-4″ in the TOCSY spectra, as well as examination of DEPT, HMQC, and HMBC data. 9, 10 The connection between feruloyl and glucose was confirmed by the HMBC correlations (Fig. 2 ) from H-6′ (δH 4.30, 4.51) to C-9 (δC 169.9). The chemical shift of C-1″ (δC 74.1) and three-bond correlations between H-1″ (δH 4.11 and 3.69) and C-1′ (δC 105.8) made it possible to locate the hexane-1,2,3,4,5-pentanol on C-1′. However, the absolute configurations of the sugars in 1 were not determined. Therefore, the structure of this compound (1) Among the isolates, the two new compounds 1 and 2 were tested for cytotoxicity against three human cancer cell lines, Lu1 (lung cancer), LNCaP (prostate cancer), and MCF-7 (breast cancer) but were found to be inactive (ED50 > 10 µg/mL).
Experimental Section
General procedures. Optical rotation was measured with a JASCO DIP-1000 digital polarimeter (Tokyo, Japan). FAB-MS spectra were obtained on a JEOL JMS-AX505WA. UV and IR spectra were recorded on a Shimadzu UV-2101 and JASCO FT/IR-300E, respectively. Extraction and isolation. The aerial parts of P. scandens (3.0 kg) were dried at room temperature and then extracted with MeOH. The MeOH extract (340 g) was concentrated in vacuo into a residue, which was suspended with water and then subsequently partitioned with n-hexane (2 L), CH 2 Cl 2 (2 L), EtOAc (2 L), and n-BuOH (2 L), successively. The n-BuOH soluble fraction (46.0 g) was fractionated using silica gel column chromatography (CHCl3-MeOH = 10:1→1:1) into twelve fractions (PB 1~12). The PB 8 fraction (3.3 g) was subjected to reversedphase C18 column chromatography (MeOH-H2O = 2:8→5:5) and produced four sub-fractions (PB 81~84). The PB 83 was applied to Sephadex LH-20 (MeOH) and then separated using HPLC (MeCN-H2O = 17:83, 2 mL/min) to yield compound 2 (5.0 mg, tR 32.9 min). The PB 9 (2.7 g) was subjected to reversed-phase C18 column chromatography (MeOH-H2O = 2:8→ 5:5) and produced five sub-fractions (PB 91~PB 95). The combined PB 92 and PB 93 was fractionated by Sephadex LH-20 into four fractions (PB 931~934). From the PB 934, compound 1 (3.4 mg, tR 36.47 min) was purified using HPLC (MeCN-H2O = 17:83, 2 mL/min). The PB 94 was subjected to Sephadex LH-20 (MeOH) and yielded four sub-fractions (PB 941~944). The PB 943 was applied to HPLC (MeCN-H2O = 10:90, 2 mL/min) and afforded compounds 3 (34 mg, t R 13.41 min) and 4 (10.0 mg, tR 17.86 min). Table 1 . Cytotoxicity evaluation. All the isolates were assessed with the Lu1 (human lung carcinoma), LNCaP (hormone-dependent human prostate carcinoma), and MCF-7 cancer cell lines, using established protocols. 
